Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Gruber JF"'
Autor:
Shi XC; Acumen LLC, Burlingame, CA, USA. Electronic address: xshi@acumenllc.com., Gruber JF; U.S. Food and Drug Administration, Silver Spring, MD, USA. Electronic address: Joann.Gruber@fda.hhs.gov., Ondari M; Acumen LLC, Burlingame, CA, USA. Electronic address: mondari@acumenllc.com., Lloyd PC; U.S. Food and Drug Administration, Silver Spring, MD, USA. Electronic address: Patricia.Lloyd@fda.hhs.gov., Freyria Duenas P; Acumen LLC, Burlingame, CA, USA. Electronic address: pduenas@acumenllc.com., Clarke TC; U.S. Food and Drug Administration, Silver Spring, MD, USA. Electronic address: Tainya.Clarke@fda.hhs.gov., Nadimpalli G; Acumen LLC, Burlingame, CA, USA. Electronic address: gnadimpalli@acumenllc.com., Cho S; U.S. Food and Drug Administration, Silver Spring, MD, USA. Electronic address: Sylvia.Cho@fda.hhs.gov., Feinberg L; Acumen LLC, Burlingame, CA, USA. Electronic address: lfeinberg@acumenllc.com., Hu M; Acumen LLC, Burlingame, CA, USA. Electronic address: mhu@acumenllc.com., Chillarige Y; Acumen LLC, Burlingame, CA, USA. Electronic address: ychillarige@acumenllc.com., Kelman JA; Centers for Medicare & Medicaid Services, Washington, DC, USA. Electronic address: Jeffrey.Kelman@cms.hhs.gov., Forshee RA; U.S. Food and Drug Administration, Silver Spring, MD, USA. Electronic address: Richard.Forshee@fda.hhs.gov., Anderson SA; U.S. Food and Drug Administration, Silver Spring, MD, USA. Electronic address: Steven.Anderson@fda.hhs.gov., Shoaibi A; U.S. Food and Drug Administration, Silver Spring, MD, USA. Electronic address: Azadeh.Shoaibi@fda.hhs.gov.
Publikováno v:
Vaccine [Vaccine] 2024 May 31; Vol. 42 (15), pp. 3486-3492. Date of Electronic Publication: 2024 May 03.
Autor:
Ogilvie RP; Optum Epidemiology, Boston, MA, USA., Layton JB; RTI Health Solutions, 3040 East Cornwallis Rd, PO Box 12194, Research Triangle Park, NC, 27709, USA. jblayton@rti.org., Lloyd PC; US Food and Drug Administration, Silver Spring, MD, USA., Jiao Y; Acumen, LLC, Burlingame, CA, USA., Djibo DA; CVS Health, Blue Bell, PA, USA., Wong HL; US Food and Drug Administration, Silver Spring, MD, USA., Gruber JF; US Food and Drug Administration, Silver Spring, MD, USA., Parambi R; Optum Epidemiology, Boston, MA, USA., Deng J; Optum Epidemiology, Boston, MA, USA., Miller M; Optum Epidemiology, Boston, MA, USA., Song J; Optum Epidemiology, Boston, MA, USA., Weatherby LB; Optum Epidemiology, Boston, MA, USA., Peetluk L; Optum Epidemiology, Boston, MA, USA., Lo AC; Acumen, LLC, Burlingame, CA, USA., Matuska K; Acumen, LLC, Burlingame, CA, USA., Wernecke M; Acumen, LLC, Burlingame, CA, USA., Bui CL; RTI Health Solutions, 3040 East Cornwallis Rd, PO Box 12194, Research Triangle Park, NC, 27709, USA., Clarke TC; US Food and Drug Administration, Silver Spring, MD, USA., Cho S; US Food and Drug Administration, Silver Spring, MD, USA., Bell EJ; Optum Epidemiology, Boston, MA, USA., Yang G; Optum Serve, Falls Church, VA, USA., Amend KL; Optum Epidemiology, Boston, MA, USA., Forshee RA; US Food and Drug Administration, Silver Spring, MD, USA., Anderson SA; US Food and Drug Administration, Silver Spring, MD, USA., McMahill-Walraven CN; CVS Health, Blue Bell, PA, USA., Chillarige Y; Acumen, LLC, Burlingame, CA, USA., Anthony MS; RTI Health Solutions, 3040 East Cornwallis Rd, PO Box 12194, Research Triangle Park, NC, 27709, USA., Seeger JD; Optum Epidemiology, Boston, MA, USA., Shoaibi A; US Food and Drug Administration, Silver Spring, MD, USA.
Publikováno v:
BMC pediatrics [BMC Pediatr] 2024 Apr 26; Vol. 24 (1), pp. 276. Date of Electronic Publication: 2024 Apr 26.
Autor:
Hu M; Acumen LLC, Burlingame, California., Shoaibi A; US Food and Drug Administration, Silver Spring, Maryland., Feng Y; Acumen LLC, Burlingame, California., Lloyd PC; US Food and Drug Administration, Silver Spring, Maryland., Wong HL; US Food and Drug Administration, Silver Spring, Maryland., Smith ER; Acumen LLC, Burlingame, California., Amend KL; Optum Epidemiology, Boston, Massachusetts., Kline A; CVS Health/Aetna, Blue Bell, Pennsylvania., Beachler DC; Carelon Research, Wilmington, Delaware., Gruber JF; US Food and Drug Administration, Silver Spring, Maryland., Mitra M; Acumen LLC, Burlingame, California., Seeger JD; Optum Epidemiology, Boston, Massachusetts., Harris C; CVS Health/Aetna, Blue Bell, Pennsylvania., Secora A; IQVIA, Falls Church, Virginia., Obidi J; US Food and Drug Administration, Silver Spring, Maryland., Wang J; Acumen LLC, Burlingame, California., Song J; Optum Epidemiology, Boston, Massachusetts., McMahill-Walraven CN; CVS Health/Aetna, Blue Bell, Pennsylvania., Reich C; IQVIA, Falls Church, Virginia., McEvoy R; Acumen LLC, Burlingame, California., Do R; Acumen LLC, Burlingame, California., Chillarige Y; Acumen LLC, Burlingame, California., Clifford R; Optum Epidemiology, Boston, Massachusetts., Cooper DD; CVS Health/Aetna, Blue Bell, Pennsylvania., Forshee RA; US Food and Drug Administration, Silver Spring, Maryland., Anderson SA; US Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
JAMA network open [JAMA Netw Open] 2024 Apr 01; Vol. 7 (4), pp. e248192. Date of Electronic Publication: 2024 Apr 01.
Autor:
Layton JB; RTI Health Solutions, Research Triangle Park, NC, USA., Peetluk L; Optum Epidemiology, Boston, MA, USA., Wong HL; US Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA., Jiao Y; Acumen, LLC, Burlingame, CA, USA., Djibo DA; Safety, Surveillance & Collaboration, CVS Health, Blue Bell, PA, USA., Bui C; RTI Health Solutions, Research Triangle Park, NC, USA., Lloyd PC; US Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA., Gruber JF; US Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA., Miller M; Optum Epidemiology, Boston, MA, USA., Ogilvie RP; Optum Epidemiology, Boston, MA, USA., Deng J; Optum Epidemiology, Boston, MA, USA., Parambi R; Optum Epidemiology, Boston, MA, USA., Song J; Optum Epidemiology, Boston, MA, USA., Weatherby LB; Optum Epidemiology, Boston, MA, USA., Lo AC; Acumen, LLC, Burlingame, CA, USA., Matuska K; Acumen, LLC, Burlingame, CA, USA., Wernecke M; Acumen, LLC, Burlingame, CA, USA., Clarke TC; US Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA., Cho S; US Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA., Bell EJ; Optum Epidemiology, Boston, MA, USA., Seeger JD; Optum Epidemiology, Boston, MA, USA., Yang GW; Optum Serve, Falls Church VA, USA., Illei D; RTI International, Washington, DC, USA., Forshee RA; US Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA., Anderson SA; US Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA., McMahill-Walraven CN; Safety, Surveillance & Collaboration, CVS Health, Blue Bell, PA, USA., Chillarige Y; Acumen, LLC, Burlingame, CA, USA., Amend KL; Optum Epidemiology, Boston, MA, USA., Anthony MS; RTI Health Solutions, Research Triangle Park, NC, USA., Shoaibi A; US Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA.
Publikováno v:
Vaccine: X [Vaccine X] 2024 Jan 20; Vol. 16, pp. 100447. Date of Electronic Publication: 2024 Jan 20 (Print Publication: 2024).
Autor:
Hu M; Acumen, Burlingame, California., Wong HL; US Food and Drug Administration, Silver Spring, Maryland., Feng Y; Acumen, Burlingame, California., Lloyd PC; US Food and Drug Administration, Silver Spring, Maryland., Smith ER; Acumen, Burlingame, California., Amend KL; Optum Epidemiology, Boston, Massachusetts., Kline A; CVS Health Clinical Trial Services, Blue Bell, Pennsylvania., Beachler DC; HealthCore, Wilmington, Delaware., Gruber JF; US Food and Drug Administration, Silver Spring, Maryland., Mitra M; Acumen, Burlingame, California., Seeger JD; Optum Epidemiology, Boston, Massachusetts., Harris C; CVS Health Clinical Trial Services, Blue Bell, Pennsylvania., Secora A; IQVIA, Falls Church, Virginia., Obidi J; US Food and Drug Administration, Silver Spring, Maryland., Wang J; Acumen, Burlingame, California., Song J; Optum Epidemiology, Boston, Massachusetts., McMahill-Walraven CN; CVS Health Clinical Trial Services, Blue Bell, Pennsylvania., Reich C; IQVIA, Falls Church, Virginia., McEvoy R; Acumen, Burlingame, California., Do R; Acumen, Burlingame, California., Chillarige Y; Acumen, Burlingame, California., Clifford R; Optum Epidemiology, Boston, Massachusetts., Cooper DD; CVS Health Clinical Trial Services, Blue Bell, Pennsylvania., Shoaibi A; US Food and Drug Administration, Silver Spring, Maryland., Forshee R; US Food and Drug Administration, Silver Spring, Maryland., Anderson SA; US Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
JAMA pediatrics [JAMA Pediatr] 2023 Jul 01; Vol. 177 (7), pp. 710-717.
Autor:
Gruber JF; Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Epidemic Intelligence Service, Division of Scientific Education and Professional Development, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Pennsylvania Department of Health, Harrisburg, Pennsylvania, USA.; Elon University, Elon, North Carolina, USA., Morris S; Pennsylvania Department of Agriculture, Harrisburg, Pennsylvania, USA., Warren KA; Pennsylvania Department of Health, Harrisburg, Pennsylvania, USA., Kline KE; Pennsylvania Department of Health, Harrisburg, Pennsylvania, USA., Schroeder B; Pennsylvania Department of Health, Harrisburg, Pennsylvania, USA., Dettinger L; Pennsylvania Department of Health, Harrisburg, Pennsylvania, USA., Husband B; Pennsylvania Department of Health, Harrisburg, Pennsylvania, USA., Pollard K; Pennsylvania Department of Health, Harrisburg, Pennsylvania, USA., Davis C; Pennsylvania Department of Health, Harrisburg, Pennsylvania, USA., Miller J; Pennsylvania Department of Agriculture, Harrisburg, Pennsylvania, USA., Weltman A; Pennsylvania Department of Health, Harrisburg, Pennsylvania, USA., Mattioli M; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Ray L; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Tarr C; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Longenberger AH; Pennsylvania Department of Health, Harrisburg, Pennsylvania, USA.
Publikováno v:
Foodborne pathogens and disease [Foodborne Pathog Dis] 2021 Jul; Vol. 18 (7), pp. 448-454. Date of Electronic Publication: 2021 Apr 27.
Autor:
Krause KH, Gruber JF, Ailes EC, Anderson KN, Fields VL, Hauser K, Howells CL, Longenberger A, McClung N, Oakley LP, Reefhuis J, Honein MA, Watkins SM
Publikováno v:
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2021 Jan 15; Vol. 70 (2), pp. 40-45. Date of Electronic Publication: 2021 Jan 15.
Autor:
Gruber JF, Newman A, Egan C, Campbell C, Garafalo K, Wolfgang DR, Weltman A, Kline KE, Watkins SM, Robbe-Austerman S, Quance C, Thacker T, Kharod G, Negron ME, Schroeder B
Publikováno v:
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2020 Apr 17; Vol. 69 (15), pp. 482-483. Date of Electronic Publication: 2020 Apr 17.
Pharmacist insights into adolescent human papillomavirus vaccination provision in the United States.
Autor:
Islam JY; a Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill , Chapel Hill , NC , USA., Gruber JF; a Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill , Chapel Hill , NC , USA., Kepka D; b College of Nursing & Huntsman Cancer Institute, University of Utah , Salt Lake City , UT , USA., Kunwar M; c Department of Maternal and Child Health, Gillings School of Global Public Health, University of North Carolina at Chapel Hill , Chapel Hill , NC , USA., Smith SB; a Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill , Chapel Hill , NC , USA., Rothholz MC; d American Pharmacists Association , Washington , DC , USA., Brewer NT; e Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill , Chapel Hill , NC , USA.; f UNC Lineberger Comprehensive Cancer Center, University of North Carolina , Chapel Hill , NC , USA., Smith JS; a Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill , Chapel Hill , NC , USA.; f UNC Lineberger Comprehensive Cancer Center, University of North Carolina , Chapel Hill , NC , USA.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2019; Vol. 15 (7-8), pp. 1839-1850. Date of Electronic Publication: 2019 Feb 06.
Autor:
Gruber JF; Department of Epidemiology, University of North Carolina (UNC)-Chapel Hill, Chapel Hill, NC., Becker-Dreps S; Department of Epidemiology, University of North Carolina (UNC)-Chapel Hill, Chapel Hill, NC.; Department of Family Medicine, UNC-Chapel Hill, Chapel Hill, NC., Hudgens MG; Department of Biostatistics, UNC-Chapel Hill, Chapel Hill, NC., Brookhart MA; Department of Epidemiology, University of North Carolina (UNC)-Chapel Hill, Chapel Hill, NC., Thomas JC; Department of Epidemiology, University of North Carolina (UNC)-Chapel Hill, Chapel Hill, NC.; MEASURE Evaluation, Carolina Population Center, UNC-Chapel Hill, NC., Jonsson Funk M; Department of Epidemiology, University of North Carolina (UNC)-Chapel Hill, Chapel Hill, NC.
Publikováno v:
Epidemiology (Cambridge, Mass.) [Epidemiology] 2018 Nov; Vol. 29 (6), pp. 867-875.